The nucleus accumbens (NAc) is a critical brain area for reward and motivated behavior. Accumulating evidence suggests that altered function of the transcription factor CREB (cAMP response element binding protein) within the NAc is involved in depressive behavior. In rats, stress activates CREB within the NAc, and elevation of CREB expression in this region produces depressive-like behaviors that are accompanied by activation of CREB-regulated target genes. The depressive-like behaviors appear to be due, at least in part, to CREB-mediated increases in dynorphin function, since they are mimicked by kappa-opioid receptor (KOR) agonists and attenuated by KOR antagonists. We hypothesized that if CREB-mediated dynorphin expression in the NAc contributes to depressive behavior, then antidepressants might reduce dynorphin function in this region. Here we demonstrate that desipramine (DMI), a norepinephrine reuptake inhibitor that has been used for decades to treat clinical depression, blocks swim stress-induced activation of prodynorphin (the gene encoding dynorphin) in the NAc. In primary cultures of NAc and striatum, DMI decreases basal and stimulated CREB phosphorylation by causing reductions in intracellular calcium (Ca 2+ ) availability that are independent of NE or other monoaminergic inputs, identifying a potential mechanism for alterations in CREB-mediated gene expression. Fluoxetine (FLX), a selective serotonin reuptake inhibitor, has similar effects in culture, suggesting a common intracellular effect of these antidepressants. These findings raise the possibility that a therapeutically relevant mechanism of action of DMI occurs through attenuation of CREB-mediated gene transcription, which is mediated via previously uncharacterized mechanisms occurring directly within the NAc.
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ABSTRACT
The nucleus accumbens (NAc) is a critical brain area for reward and motivated behavior. Accumulating evidence suggests that altered function of the transcription factor CREB (cAMP response element binding protein) within the NAc is involved in depressive behavior. In rats, stress activates CREB within the NAc, and elevation of CREB expression in this region produces depressive-like behaviors that are accompanied by activation of CREB-regulated target genes. The depressive-like behaviors appear to be due, at least in part, to CREB-mediated increases in dynorphin function, since they are mimicked by kappa-opioid receptor (KOR) agonists and attenuated by KOR antagonists. We hypothesized that if CREB-mediated dynorphin expression in the NAc contributes to depressive behavior, then antidepressants might reduce dynorphin function in this region. Here we demonstrate that desipramine (DMI), a norepinephrine reuptake inhibitor that has been used for decades to treat clinical depression, blocks swim stress-induced activation of prodynorphin (the gene encoding dynorphin) in the NAc. In primary cultures of NAc and striatum, DMI decreases basal and stimulated CREB phosphorylation by causing reductions in intracellular calcium (Ca 2+ ) availability that are independent of NE or other monoaminergic inputs, identifying a potential mechanism for alterations in CREB-mediated gene expression. Fluoxetine (FLX), a selective serotonin reuptake inhibitor, has similar effects in culture, suggesting a common intracellular effect of these antidepressants. These findings raise the possibility that a therapeutically relevant mechanism of action of DMI occurs through attenuation of CREB-mediated gene transcription, which is mediated via previously uncharacterized mechanisms occurring directly within the NAc.
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INTRODUCTION
Decreased motivation and reduced ability to experience reward (anhedonia) are prominent signs of clinical depression (APA, 2000) , suggesting that brain reward circuits such as the mesolimbic dopamine system are involved in the neurobiology of depressive behaviors. This system comprises dopamine (DA)-containing neurons originating within the ventral tegmental area (VTA) and projecting to the nucleus accumbens (NAc). Although the NAc is often associated with the rewarding effects of drugs of abuse, it is also a substrate for natural rewards including food, sex, and social interaction (Wise, 2004) . In rodents, manipulations within the NAc produce behaviors that may model aspects of clinical depression, including anhedonia, dysphoria, and behavioral despair (Harris and Aston-Jones, 1994; Pliakas et al., 2001; Wise, 2004) .
Although the NAc has not been a major focus of depression research, it innervatesand is innervated by-regions often studied in depressed humans, including the hippocampus, frontal cortex, and amygdala (Nestler and Carlezon, 2006) . Additionally, norepinephrine (NE) and serotonin (5HT) inputs modulate the NAc (Pasquier et al., 1977) .
Neuroadaptations within the NAc contribute to the development of depressive-like behaviors. Stress elevates activity of the transcription factor cAMP response element binding protein (CREB) within the NAc (Pliakas et al., 2001) . Elevated CREB function within the NAc increases depressive-like behavior in the forced swim test (FST) (Pliakas et al., 2001) , a model often used to study depression . Furthermore, elevated CREB reduces the motivational impact of drugs and natural rewards, a sign of This article has not been copyedited and formatted. The final version may differ from this version. 5 anhedonia (Carlezon et al., 1998) . The depressive-like behavioral effects that accompany elevated NAc CREB function appear related to altered transcription of dynorphin (Carlezon et al., 1998) , an endogenous peptide that acts at kappa-opioid receptors (KORs) (Chavkin et al., 1982) . Disruption of CREB function within the NAc produces antidepressant-like effects (Pliakas et al., 2001 ) accompanied by decreases in dynorphin expression (Carlezon et al., 1998) . Similarly, KOR antagonists attenuate the behavioral effects of elevated CREB expression within the NAc, and have antidepressant-like effects (Mague et al., 2003; McLaughlin et al., 2003; Newton et al., 2002; Pliakas et al., 2001) . These findings are consistent with observations that KOR agonists produce depressive signs in humans (Pfeiffer et al., 1986) and rats (Mague et al., 2003; Shippenberg and Herz, 1987; Todtenkopf et al., 2004) . Thus there are strong links between CREB-mediated regulation of dynorphin within the NAc and depressive behavior.
The present studies were designed to test the hypothesis that if CREB function in the NAc contributes to depressive behavior, then desipramine (a NE-reuptake inhibitor used for decades to treat clinical depression; Frazer, 1997) might affect CREB-regulated gene expression within this brain region. We first examined the effects of DMI on stress-induced alterations in dynorphin expression within the NAc. We then used an in vitro model (primary cell cultures of NAc/striatum) to explore potential intracellular mechanisms of this effect. For comparison, we also examined the in vitro effects of fluoxetine (FLX), a selective serotonin reuptake inhibitor with clinical efficacy similar to DMI (Frazer, 1997) .
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MATERIALS AND METHODS
Rats
Thirty-three male Sprague Dawley rats (325-375 gm) (Charles River, Boston) were used for analysis of prodynorphin expression. These rats were housed in groups of 4 in a climate-controlled vivarium and maintained on a 12 hr light (0700-1900 hr)-12 hr dark cycle with free access to food and water except during surgery and testing. In addition, 16 timed-pregnant Sprague Dawley rats were used to obtain embryonic day 18 (E18)
tissue for the primary cell culture studies. These rats were used on the day of delivery.
Experiments were conducted in accordance with the 1996 Guide for the Care and Use of Laboratory Animals (NIH), as well as McLean Hospital policies.
Drugs
For in vivo studies in rats, desipramine hydrochloride (DMI; Sigma, St. Louis MO) was dissolved in distilled water vehicle, and administered in a volume of 1.0 ml/kg. For in vitro studies in the NAc/striatal primary cultures, DMI, fluoxetine hydrochloride (FLX; Sigma), potassium chloride (KCl; Fisher Scientific), SKF 82958 (Sigma), and N-Methyl-D-aspartic acid (NMDA; Sigma) were dissolved in sterile ultra-pure water. FPL 64176 and thapsigargin (Sigma) were dissolved in dimethyl sulfoxide (DMSO). Phorbol 12-myristate 13-acetate (PMA; Sigma) was dissolved in 100% ethanol. SKF 82958 was administered directly to cell culture media at 50x concentration (20 μl drug into 1000 μl media/well) whereas all other drugs were administered at 100X concentration (10 μl This article has not been copyedited and formatted. The final version may differ from this version. 
Real-time reverse transcriptase polymerase chain reaction (Q-PCR)
Thirty-three rats were used to determine the effects of DMI and forced swimming on prodynorphin gene expression within the NAc shell. The standard forced swim test (FST) is a 2-d procedure in which rats swim under conditions in which escape is not possible. On the first day, rats are forced to swim for 15 min. At first the rats attempt to escape from the water, but eventually they adopt a posture of immobility in which they make only the movements necessary to keep their heads above water. When the rats are retested 24 hr later, the latency to immobility is decreased. Treatment with standard antidepressant drugs within the 24 hr between the first and second exposures to forced swimming can block facilitated immobility, an effect associated with antidepressant efficacy in humans (Detke et al., 1995) . In this study, we sacrificed the rats on day 2, at the time when they would have experienced their second exposure to forced swimming.
There were 4 treatment groups (6-13 rats per group): sham (no swim), sham plus DMI, forced swim (FS), and FS plus DMI. On the first day of the experiment, rats were forced to swim for 15 min as described above. Sham-treated rats were placed on a platform set at a height of 45 cm inside a dry Plexiglas cylinder for 15 min, to mimic as closely as possible the FST without actually exposing the rats to forced swimming. After the first forced swimming or sham session, rats were towel-dried and warmed for 30 min. All rats were then injected IP with either saline or DMI (10 mg/kg) at 1, 19, and 23 hr after the forced swimming session. At 24 hr after the first swimming session, the rats were This article has not been copyedited and formatted. The final version may differ from this version. were run with the dilution curves to control for contamination. All samples were run in duplicate and reported values were normalized to the internal standard ß-actin. Data are expressed as mean relative levels of prodynorphin/ß-actin mRNA ± SEM and were analyzed using a one-way ANOVA followed by Fisher's protected t tests.
Primary cultures of NAc and striatum
Primary cultures were prepared as described (Chartoff et al., 2003) . Briefly, striata 
Studies of P-CREB induction
In order to study the effects of antidepressants on P-CREB in NAc tissue, we treated neuronal cultures with either DMI or FLX for either 1 hr (intended to correspond with immediate, acute effects) or 24 hr (intended to correspond with longer-term, chronic effects). For studies investigating the effects of DMI on basal P-CREB levels, DMI was added to the tissue culture media either 24 or 1 hr prior to cell harvesting. For studies investigating the effects of antidepressant drugs on the activation of P-CREB by cellular depolarization, DMI or FLX was added to the media either 21 or 1 hr prior to KCl (40 mM), and the cells were harvested 3 hr later. This time course is based on previously published work (Schwaninger et al., 1995) . To determine the mechanisms by which DMI and FLX might be attenuating CREB function, several pathways known to activate CREB were investigated. DMI was administered 1 hr prior to SKF 82958 (DA D1-selective agonist), FPL 64176 (L-type Ca 2+ channel activator), PMA (protein kinase C activator), NMDA, or thapsigargin, (sarco-endoplasmic reticulum Ca 2+ -ATPase inhibitor, which increases levels of free cytosolic Ca 2+ (Treiman et al., 1998) , and the cells were harvested 15 min later.
Western blot analysis
This article has not been copyedited and formatted. The final version may differ from this version. Primary rat NAc/striatal cultures were harvested in NuPAGE LDS (lithium dodecyl sulfate) sample buffer (Invitrogen) and 50 mM dithiothreitol as described (Chartoff et al., 2003) . (Sigma). SeeBlue Plus 2 (Invitrogen) pre-stained standards were run for molecular weight estimation. P-CREB and CREB bands were detected at 43 kDa, and β-actin was detected at 42 kDa.
Protein immunoblots were analyzed using Kodak 1D Image Analysis software (Kodak, This article has not been copyedited and formatted. The final version may differ from this version. Rochester, NY). Relative optical densities were determined for each band of interest.
To control for loading differences of protein, the optical density of each band was normalized with the corresponding optical density of β-actin. To allow for comparisons of blots from independent dissections, data were normalized to the vehicle-treated controls in each experiment. Data are expressed as the mean fold induction compared to vehicle control ± SEM and were analyzed using one-way ANOVAs followed by
Fisher's protected t tests.
Live/dead assay
To determine if DMI is cytotoxic to striatal cultures, a Live/Dead Viability/Cytotoxicity Kit (Molecular Probes, Eugene, OR) was used. Cells were plated on round glass cover slips as described above and treated as described in the figure legends. At the appropriate time after drug treatments, cells were washed 2x with PBS. The cover slips containing the cells were then inverted onto 150-μl drops of a dye mixture containing 1 mM calcein AM and 1 mM ethidium homodimer-1 and allowed to incubate for 30 min at room temperature in a darkened chamber containing a water-soaked Kimwipe to prevent the coverslips from drying. Cover slips were then washed briefly in PBS and placed cell-side down onto 20-μl drops of PBS on microscope slides. Visualization (Axioskop 2 plus, Zeiss, Germany) and digital image capture (Openlab 3.0.7 software; Improvision, Coventry, UK) of cells were done immediately, as the cover slips dried out after 1 hr. Live cells fluoresced green due to esterase-mediated cleavage of cellpermeant calcien AM to fluorescent calcein and were detected with an EGFP filter.
Dead cells fluoresced red due to the entry of ethidium homodimer-1 into cells with
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RESULTS
DMI blocks stress-induced prodynorphin expression
To examine the possibility that the antidepressant actions of DMI involve disruption of CREB function within the NAc, we examined its effects on local expression of prodynorphin, a gene known to be regulated by CREB (Cole et al., 1995; Douglass et al., 1994) . Stress is a major trigger for depression , and it has been shown that forced swim stress activates CREB within the NAc (Pliakas et al., 2001) expression of prodynorphin within the NAc that was sustained for at least 24 hr (P<0.05), and this effect was blocked by a treatment regimen of DMI (10 mg/kg) that produces antidepressant-like effects in the FST (Carlezon et al., 2002) . In contrast, DMI had no effect on prodynorphin mRNA levels in rats not exposed to forced swim stress.
Visualization confirmed that the prodynorphin and ß-actin amplicons were the expected size on a polyacrylamide gel ( Figure 1B) .
Effects of DMI on CREB function in dissociated NAc/striatal cultures
The NAc receives relatively minor NE input (Delfs et al., 1998) , raising the possibility that the ability of DMI to block FS stress-induced prodynorphin in the NAc is due either to indirect circuit effects or to direct effects on NAc function that are independent of NE reuptake blockade. To test whether DMI can act directly on post-synaptic cells in the NAc to modulate intracellular signaling, we used primary cultures of dissociated embryonic (E18) rat NAc and striatal tissue. We treated these cultures for 1 hr or 24 hr with DMI and measured the relative levels of CREB protein or CREB phosphorylated at serine residue 133 (P-CREB). One-hour treatment with DMI decreased basal P-CREB levels (F (5,209) = 7.59; P<0.01) without affecting total CREB protein (F (5,21) = 0.15 ; not significant) (Figure 2A) . Twenty four-hour treatment with DMI had a bimodal effect on P-CREB levels (F (5,171) = 22.0; P<0.01) ( Figure 2B ): intermediate doses of DMI increased (P's<0.01) basal P-CREB, whereas a high dose (3000 nM) decreased it (P<0.01). Interestingly, the high dose of 24-hr DMI (3000 nM) increased levels of CREB protein (F (5,57) =6.79; P<0.01) ( Figure 2B ). Inasmuch as it has been reported previously that chronic treatment with antidepressant drugs increased both CREB mRNA levels This article has not been copyedited and formatted. The final version may differ from this version. 15 and CREB function in the hippocampus (Nibuya et al., 1996) , our data indicate that CREB-mediated plasticity is complex and likely brain area-dependent (Carlezon et al., 2005) .
The decrease in P-CREB observed with 24-hr DMI (3000 nM) treatment could be due to cellular toxicity. Recently it has been shown that high concentrations of DMI (20 mM)
can induce cell death in a neural cell line (Post et al., 2000) . Although the doses of DMI used in our studies did not approach this level, the propensity of DMI to cause toxicity in primary NAc and striatal cultures is unknown. We found that DMI had no effect on cell viability when cultures were treated for 24 hr with the highest concentration of the drug (3000 nM), whereas a brief treatment with 70% methanol caused 100% cell death (F (2,6) 35.4, P<0.01) ( Figure 2C) . Similarly, we did not observe any effects of 1-hr DMI (3000 nM) treatment on cell viability (data not shown).
To examine if DMI regulates CREB under conditions of heightened neuronal activation-similar to what may occur in the brain during periods of stress-we depolarized the cell cultures with KCl (40 mM). This has been shown to activate CRE (cAMP response element)-mediated gene transcription by influx of Ca 2+ through L-type voltage-dependent Ca 2+ channels (Sheng et al., 1990) . Addition of KCl to the cultures induced robust increases in P-CREB, which were dose-dependently attenuated by both 1 hr DMI pretreatment (F (5,155) = 34.1; P<0.01) ( Figure 3A ; solid black bars) and 24 hr DMI pretreatment (F (5,128) = 20.4; P<0.01) ( Figure 3B ; solid black bars).
This article has not been copyedited and formatted. The final version may differ from this version. (Cai and McCaslin, 1992; Choi et al., 1992; Shimizu et al., 1994) . We found that 1-hr pretreatment with DMI had no effect on the induction of Table 1 ). In contrast, 1-hr (F (3,29) = 18.9; P<0.01) pretreatment with DMI inhibited P-CREB induced by thapsigargin (100 nM; blocks uptake of Ca 2+ into intracellular stores), and 24-hr (F 3,74 = 5.713; P<0.01) pretreatment with DMI (3000 nM) attenuated (trend, P=0.091) thapsigargin-induced P-CREB (Figure   4A , B; black bars). Finally, 1-hr pretreatment with DMI had no effect on P-CREB induced by the D1 agonist SKF 82958 (F (2,9) = 13.9; P<0.01) ( Table 1) , further suggesting a specific role for Ca 2+ in mediating the effects of DMI.
Effects of FLX on CREB function in dissociated NAc/striatal cultures
To determine whether the ability of DMI to reduce CREB function within the NAc and striatum through inhibition of signaling pathways activated by intracellular Ca 2+ release was specific to DMI or generalizable to other classes of antidepressant drugs, we tested the effects of fluoxetine (FLX), a selective serotonin reuptake inhibitor (SSRI), on KCland thapsigargin-stimulated P-CREB in primary cultures of the NAc and striatum. We found that both 1-hr (F 3,62 = 30.897; P<0.01) and 24-hr (F 3,62 = 13.389; P<0.01) pretreatments with FLX attenuated KCl-induced P-CREB (Figure 5A , B; black bars).
This article has not been copyedited and formatted. The final version may differ from this version. pretreatments with FLX inhibited thapsigargin-induced P-CREB (Figure 5C , D; black bars). Similar to our findings with DMI, 1-hr FLX reduced basal P-CREB ( Figure 5C , inset) (F 2,24 = 12.30; P<0.001). Twenty four-hr FLX, however, slightly increased basal P-CREB at the highest dose tested (Figure 5D, inset) , but did not show the bimodal effect on P-CREB observed with DMI (F 2,27 = 1.25; ns). Similar to DMI, 1-hr FLX had no effect on FPL-induced P-CREB (data not shown). Hence, despite distinct pharmacological profiles, both DMI and FLX appear to act via a common mechanism within the NAc and striatum.
DISCUSSION
The NE reuptake inhibitor DMI decreases CREB function and prodynorphin expression in the NAc, supporting the hypothesis that increased CREB function in the NAc contributes to depressive-like behaviors (Carlezon et al., 2005) . We demonstrate this in two distinct but complementary ways. First, we found that swim stress-induced activation of prodynorphin within the NAc is blocked by a DMI regimen that produces antidepressant-like effects in the FST. Second, we used primary cultures of embryonic NAc and striatal tissue to show that DMI reduced CREB function. The SSRI FLX had similar effects in studies designed to determine if this in vitro effect was shared by other types of antidepressant drugs. These findings support behavioral and molecular evidence suggesting that activation of CREB within the NAc is critically involved in depressive-like behavior (Conti et al., 2002; Newton et al., 2002; Pliakas et al., 2001 ).
This article has not been copyedited and formatted. The final version may differ from this version. The observation that forced swimming increases prodynorphin expression within the NAc extends our previous finding that swim stress activates CREB in this region (Pliakas et al., 2001) , and provides a potential explanation for why stressors might cause subsequent increases in depressive-like behavior. Dynorphin appears to play an important role in regulating mood via actions at KORs. There is substantial evidence that KORs are expressed on DA terminals within the NAc (Svingos et al., 2001 ).
Stimulation of these receptors reduces mesolimbic system function and decreases levels of extracellular DA, effects thought to contribute to depressive-like states Wise, 1982) . Indeed, KOR agonists produce depressive-like effects (Bals-Kubik et al., 1993; Carlezon et al., 2006; Mague et al., 2003; Todtenkopf et al., 2004) , whereas KOR antagonists have antidepressant-like effects (Mague et al., 2003; Newton et al., 2002; Pliakas et al., 2001) , even when restricted to the NAc (Newton et al., 2002) . Our finding that DMI blocks stress-induced activation of prodynorphin within the NAc provides new links among the antidepressant-like effects of this drug, the antidepressant-like effects of disrupting CREB function (and subsequent prodynorphin expression) in this region (Pliakas et al., 2001) , and the antidepressantlike effects of NAc microinjections of KOR antagonists (Newton et al., 2002) .
Effects of DMI and FLX in vitro
To understand the mechanism by which DMI blocks swim stress-induced prodynorphin expression, we utilized dissociated cultures of NAc and striatal tissue to examine the effects of DMI on CREB and CREB phosphorylation-a marker of CREB activation (Mayr and Montminy, 2001) . In humans and in animal models of depression, the This article has not been copyedited and formatted. The final version may differ from this version. Considering that CREB protein levels remain unaltered by DMI at doses that significantly affect P-CREB, our in vivo finding that the DMI-mediated reduction in stress-activated prodynorphin expression within the NAc is likely due to attenuated CREB phosphorylation rather than reduced CREB levels.
Twenty four-hr pretreatment with DMI had bimodal effects on basal P-CREB:
intermediate doses of DMI increased P-CREB, whereas a high dose decreased it. This is consistent with the observation that DMI alone slightly increases CRE-mediated transcription in cultured cell lines (Schwaninger et al., 1995) . However, it does not fit well with our in vivo finding that DMI reduces stress-activated prodynorphin expression within the NAc. Since these findings were from cell cultures in a basal or "normal" state, (Schwaninger et al., 1995) indicating that DMI can attenuate the intracellular signaling events that lead to depolarization-induced P-CREB in a variety of cell phenotypes.
The ability of DMI to disrupt CREB function within the NAc tissue appears to involve, at least in part, effects on intracellular Ca 2+ storage. DMI attenuates the ability of thapsigargin-induced increases in intracellular Ca 2+ to phosphorylate CREB.
Thapsigargin inhibits sarco-endoplasmic reticulum Ca 2+ -ATPase (SERCA) pumps, which actively pump Ca 2+ into intracellular stores (SER). SERCA inhibition results in increased cytosolic Ca 2+ levels, which in turn can trigger waves of Ca 2+ -induced Ca 2+ release through activation of ryanodine receptors on the SER. The resultant calcium "waves" can activate calcium-regulated signal transduction pathways that lead to CREB phosphorylation. In our in vitro studies with NAc and striatal neuronal cultures, DMI had no effect on P-CREB stimulated by the L-type Ca 2+ channel agonist FPL 64176 or NMDA, suggesting that DMI does not modulate Ca 2+ entry through these specific ion channels. This is in apparent contrast to several previous studies showing that tricyclic antidepressants suppress Ca 2+ entry through voltage sensitive Ca 2+ channels and inhibit KCl-stimulated increases in intracellular Ca 2+ levels that originate from extracellular sources (Cai and McCaslin, 1992; Choi et al., 1992; Shimizu et al., 1994) . However, DMI did not completely block KCl-stimulated P-CREB, which is consistent with a partial role for intracellular stores in CREB activation. Also, our studies are unique in that we are examining P-CREB regulation rather than Ca 2+ entry, and our findings suggest that This article has not been copyedited and formatted. The final version may differ from this version. DMI-mediated decreases in P-CREB depend, at least in part, on targeting of intracellular Ca 2+ stores. We also show that DMI does not affect P-CREB stimulated by the PKC activator, PMA. PKC is activated by Ca 2+ and has been shown to phosphorylate CREB (Mao et al., 2007) . In addition, it has been shown previously that DMI does not block CaM kinase IV-induced CRE-mediated gene transcription (Schwaninger et al., 1995) . Finally, we show that DMI has no effect on P-CREB stimulated by the D1 receptor agonist SKF 82958, which is consistent with the previous finding that DMI did not alter forskolin-stimulated CRE-mediated gene transcription (Schwaninger et al., 1995) . Together, these findings raise the possibility that the effects of DMI are not due to general inhibition of Ca 2+ -or cAMP-mediated signaling cascades but rather to direct actions at SERCA pumps or at receptors that control release of Ca 2+ from the SER (e.g. ryanodine receptors).
Previously it has been shown that antidepressant drugs inhibit P-CREB and CREBmediated transcription in vitro (Schwaninger et al., 1995) . Considering the present data demonstrating the ability of Ca 2+ -stimulating agents to increase P-CREB and the known ability to P-CREB to regulate prodynorphin (Cole et al., 1995) , our finding that DMI (Kornhauser et al., 2002) . In contrast, work done in culture spinal cord neurons has shown that Ca 2+ can potentiate prodynorphin expression by binding to and removing the transcriptional repressor DREAM (Cheng et al., 2002) .
Also, in cultured myocardial cells four hours after KCl administration, prodynorphin expression is dramatically increased in a Ca 2+ -dependent manner (Ventura et al., 1994) .
Together, these findings indicate that Ca 2+ -stimulated signal transduction pathways are complex and can have a variety of effects on transcription that likely depend on cell type and brain region (see Carlezon et al., 2005) .
We hypothesized that if the effects of DMI on intracellular Ca 2+ function within the NAc contributes to the antidepressant actions of the drug, then other classes of antidepressants might have similar effects. We found that 1-hr and 24-hr treatments with FLX also attenuated KCl-stimulated P-CREB in the cell cultures. This effect can be attributed, at least in part, to a decrease in intracellular Ca 2+ function: FLX reduced thapsigargin-stimulated P-CREB. Although DMI and FLX had similar effects on P-CREB, there were minor differences. One-hr, but not 24-hr, FLX reduced basal P-CREB levels in the absence of stimulation. Also, KCl-stimulated P-CREB was less sensitive to FLX than DMI, whereas thapsigargin-stimulated P-CREB appeared more sensitive to FLX than DMI. These differences might be related to the pharmacokinetics of these drugs. In humans, steady-state serum concentrations of DMI and FLX can reach approximately 1000 and 1500 nM (Baldessarini, 2006) , which are within the range of doses we have shown to have effects on P-CREB. It is possible that, relative to DMI, slightly higher concentrations of FLX are required to modulate basal P-CREB over the This article has not been copyedited and formatted. The final version may differ from this version. 
Conclusions
We identify a novel mechanism through which DMI has direct effects on Ca 2+ -mediated signaling that lead to decreased CREB function and prodynorphin expression within the NAc. These findings are congruent with evidence that KOR blockade and Ca 2+ channel inhibitors produce antidepressant-like effects, and that inhibition of Ca 2+ influx within the NAc has reward-facilitating effects (Chartoff et al., 2006; Mague et al., 2003; Newton et al., 2002; Pliakas et al., 2001; Pucilowski, 1992) . They are also consistent with work demonstrating that deletion of CREB isoforms throughout the brain produces antidepressant-like effects (Conti et al., 2002) , and activation of CREB-regulated target genes within the mesolimbic dopamine system contribute to induction of depressive-like states (Berton et al., 2006) . Considering the growing sentiment that altered monoaminergic function alone is unlikely to explain depression or the therapeutic effects of antidepressants (Castren, 2005; Nestler and Carlezon, 2006) , our findings have important implications. First, the therapeutic effects of antidepressants including DMI might involve diminished activity of CREB-regulated target genes within the NAc.
Second, such effects may occur independently of-or in addition to-their ability to
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